In human leukaemia cell lines and in the cells of patients with chronic lymphocyte leukaemia treated with paclitaxel, there is a significant increase in the expression of cytochrome c, caspase 3 and PARP, as well as a decreased JNK activity [41]. Here, CYCS is linked to leukemia.